Certain bottles of Xanax have been recalled nationwide, according to the Food and Drug Administration (FDA). The anti-anxiety medication was initially recalled in March for “failed dissolution specifications,” meaning there was a problem with how the tablets dissolve, which could impact their effectiveness. On April 8, the FDA gave the recall the second-highest risk level, Class II, indicating the potential for temporary or reversible health consequences from the product.
According to a press release from the California State Board of Pharmacy, the risk to patients from the recalled Xanax is “negligible,” and no adverse reactions have been reported to date.
Identifying the Recalled Xanax
The recalled Xanax, available by prescription only, was made in Ireland and distributed by Viatris Specialty LLC in the U.S. from Aug 27, 2024, to May 29, 2025.
You can identify the affected bottles with the following:
- Product name: Xanax XR, alprazolam, extended-release tablets
- Size: 3 mg, 60-tablet bottles
- National Drug Code (NDC): 58151-506-91
- Lot number: 8177156
- Expiration date: 02/28/2027
What You Should Do
If you have the recalled Xanax, contact your doctor or pharmacist for a replacement, and ask about the best course of action for you. Class II recalls do carry a risk of adverse health effects, but stopping a medication could be riskier.
“While recall notifications can be frightening, it’s important to contact your healthcare provider right away for advice before making any changes to your medication routine,” Jennifer Young, PharmD, BCPS, CSP, lead medication safety specialist at the Institute for Safe Medication Practices, previously told Health. “Some medicines … should not be stopped suddenly.”
Disclaimer
Artificial Intelligence Disclosure & Legal Disclaimer
AI Content Policy.
To provide our readers with timely and comprehensive coverage, South Florida Reporter uses artificial intelligence (AI) to assist in producing certain articles and visual content.
Articles: AI may be used to assist in research, structural drafting, or data analysis. All AI-assisted text is reviewed and edited by our team to ensure accuracy and adherence to our editorial standards.
Images: Any imagery generated or significantly altered by AI is clearly marked with a disclaimer or watermark to distinguish it from traditional photography or editorial illustrations.
General Disclaimer
The information contained in South Florida Reporter is for general information purposes only.
South Florida Reporter assumes no responsibility for errors or omissions in the contents of the Service. In no event shall South Florida Reporter be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of the Service or the contents of the Service.
The Company reserves the right to make additions, deletions, or modifications to the contents of the Service at any time without prior notice. The Company does not warrant that the Service is free of viruses or other harmful components.
